HimalayasHimalayas logo
Lycia TherapeuticsLT

Lycia Therapeutics

Lycia Therapeutics is a biotechnology company using its proprietary LYTAC (lysosomal targeting chimera) platform to develop therapeutics that degrade extracellular and membrane-bound proteins driving autoimmune and inflammatory diseases.

About Lycia Therapeutics

Lycia Therapeutics is a pioneering biotechnology company developing novel therapeutics designed to eliminate disease-causing extracellular proteins. Founded in 2019, the company leverages its proprietary LYTAC (Lysosomal Targeting Chimera) platform to create therapeutics that bind target proteins and transport them into cells for degradation via the lysosome, utilizing the body's natural cellular waste disposal process.

The company's innovative approach addresses a significant gap in targeted protein degradation, which has primarily focused on proteins within cells. Lycia's LYTAC platform specifically targets disease-causing proteins that exist on the cell surface or in circulation, representing a breakthrough in treating conditions previously considered undruggable. The company's initial focus is on developing treatments for autoimmune and inflammatory diseases with high unmet medical needs. Lycia has established partnerships with major pharmaceutical companies, including a strategic collaboration with Eli Lilly to discover and develop novel LYTAC degraders for up to five targets. The company has raised over $200 million in total funding, including a $106.6 million Series C financing in May 2024, positioning it to advance its pipeline of LYTAC therapeutics into clinical development.

FAQs

When was Lycia Therapeutics founded?
Lycia Therapeutics was founded in 2019.
Who is the CEO of Lycia Therapeutics?
Aetna Wun Trombley is the CEO.
What industries or markets does Lycia Therapeutics operate in?
Lycia Therapeutics operates in the following markets: Biotechnology, Autoimmune Disease Therapeutics, Pharmaceutical R&D, Drug Discovery Platforms, Targeted Protein Degradation (TPD), Extracellular Protein Degradation, Biologics Therapeutics, Inflammatory Disease Therapeutics, Lysosomal Targeting Technologies (LYTAC), and Pharmaceutical Partnerships & Licensing.
How many employees does Lycia Therapeutics have?
Lycia Therapeutics has 11-50 employees.
Where does Lycia Therapeutics have employees?
Lycia Therapeutics has employees in United States.
Is Lycia Therapeutics hiring?
Yes, Lycia Therapeutics has 1 open remote job.
Does Lycia Therapeutics support remote work or working from home?
Yes, Lycia Therapeutics is a remote-friendly company.
Does Lycia Therapeutics offer a four-day work week?
No, Lycia Therapeutics does not offer a four-day work week.
Is Lycia Therapeutics transparent about salaries?
Yes, Lycia Therapeutics practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 1 role.
What is Lycia Therapeutics's website?
Lycia Therapeutics's website is lyciatx.com.
Where can I find Lycia Therapeutics on social media?
You can find Lycia Therapeutics on LinkedIn and Twitter.

1 remote job at Lycia Therapeutics

Explore the variety of open remote roles at Lycia Therapeutics, offering flexible work options across multiple disciplines and skill levels.

View all jobs at Lycia Therapeutics

Remote companies like Lycia Therapeutics

Find your next opportunity by exploring profiles of companies that are similar to Lycia Therapeutics. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan
Lycia Therapeutics | Himalayas